We're leading the fight against cardiovascular disease and there was great evidence of that at the world's biggest meeting of heart researchers and medics in Barcelona.
Over five days, between 29 August and 2 September, almost 30,000 cardiologists and researchers from around the world attended the European Society of Cardiology (ESC) Congress. Findings from studies we funded were presented and shared among the research community. Keith Fox, a recently retired BHF Professor, was Chair of the Congress Programme Committee.
The BHF can be very proud of its world-leading position in cardiovascular research
Professor Peter Weissberg
BHF Medical Director
Our Medical Director, Professor Peter Weissberg, commented on the conference: “The ESC is arguably the world’s foremost cardiovascular scientific meeting, attended by almost 30,000 cardiologists and researchers from across the globe. And the BHF is a dominant force within the organisation. BHF-funded researchers continue to receive accolades and awards from their international peers and
BHF-funded research is featured in high profile flagship sessions. The BHF can be very proud of its world-leading position in cardiovascular research."
The BHF's involvement in the conference
Results from three BHF-funded clinical trials were presented at the ESC including the findings of a study which could improve treatment for heart attacks. BHF Professor Barbara Casadei (pictured) spoke about her study assessing the benefits of prescribing a statin to reduce the risk of someone developing atrial fibrillation after heart bypass surgery. The results could lead to a change in current guidelines.
Professor Casadei, who is based at the University of Oxford, was also elected Vice President of the ESC Board. She will be one of just three people on that board. This is one of the highest honours in cardiology, and recognises the 20 years Professor Casadei has spent at the top of cardiovascular science. Our Associate Medical Director, Professor Jeremy Pearson, has been elected Chair-elect of the Council for Basic Cardiovascular Science.
The ESC showcased our support for the next generation of world-leading cardiovascular researchers. The Young Investigator Award for Clinical Science was won by a BHF-funded researcher at King's College London, which is a BHF Centre of Research Excellence.
The ultimate recognition
BHF Professor Sir Rory Collins (on the left in the picture) was also an award winner at the Congress. Professor Collins, who led the revolutionary Heart Protection Study among other important clinical trials, was awarded the prestigious ESC Gold Medal. Professor Collins described it as the "ultimate recognition".
Our Medical Director, Professor Peter Weissberg, said: “Thanks to the generous support of our donors and volunteers, we have been able to support BHF Professor Collins’ research for over thirty years. As co-director of the Clinical Trial Service Unit at Oxford, he has been responsible for some of the most influential clinical trials in cardiovascular medicine and has shaped the way patients with heart disease are treated. This award is well-deserved recognition for his important achievements.”
You can help us to fund more world-leading research to improve the lives of heart patients.